Gonadotropin releasing hormone agonist trigger in oocyte donors co treated with a gonadotropin releasing hormone antagonist A dose finding study

Monday, February 1, 2016
Comparable numbers of mature oocytes and top quality embryos are retrieved after the use of triptorelin doses of 0.2, 0.3, or 0.4 mg to trigger ovulation in oocyte donors.

Read More

Preferences and needs regarding future contact with donation offspring among identity release gamete donors Results from the Swedish Study on Gamete Donation

Monday, June 23, 2014
Several years after donation, a majority of 210 identity-release donors feel positive about future contact with an offspring, and their preferences should be taken into account by health-care services.

Read More

Advocating for longitudinal follow up of the health and welfare of egg donors

Friday, May 23, 2014
Although short-term health effects of donation have been well studied, many unanswered questions remain about the long-term medical and psychological consequences for women who donate eggs.

Read More

Effect of oocyte donation on pregnancy outcomes in in vitro fertilization twin gestations

Wednesday, April 30, 2014
In patients who conceive twin pregnancies using IVF, oocyte donation increases the risk of gestational hypertension and preeclampsia.

Read More

Oocyte donation and the therapeutic misconception

Tuesday, April 30, 2013
Reflections on "Egg donor informed consent tool (EDICT): Development and validation of a novel informed consent tool for oocyte donors" by Skillern et al.

Read More

Translate »